Yuan Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuan Zhou has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Chao Wang
The First People's Hospital of Changde, Changde, China
1 shared publicationDan Ou
Changde Hospital of University of South China, Changde, China
1 shared publicationDan Peng
Department of Medical Genetics, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, 415000, People's Republic of China
1 shared publication- Dan Peng
Department of Medical Genetics, Changde Hospital, Xiangya School of Medicine, Central South University (The First People’s Hospital of Changde City), Hunan Changde, China
1 shared publication Jibo Zhang
The First People's Hospital of Changde, Changde, China
1 shared publicationLihua Zhou
The First People's Hospital of Changde, Changde, China
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 2929-2945
Global Spatiotemporal Trends and Modifiable Risk Factors for Female Infertility: An Age-Period-Cohort Using Global Burden of Disease Study 2021 and Mendelian Randomization Analysis
Background: This study aims to describe the global burden of female infertility, analyze its spatial and temporal trends, and offer targeted epidemiological insights to support the prevention and management of female infertility. Methods: Drawing on insights from the GBD 2021 study, we analyzed age-standardized prevalence rates (ASPR) of female infertility (1990– 2021) across global regions and Socio-Demographic Index (SDI) categories. We quantified temporal trends using estimated annual percentage change (EAPC) and Age-Period-Cohort analyses across age groups and geographic regions. Furthermore, the causal relationships between 16 modifiable risk factors, 10 serum biomarkers, and female infertility were assessed by two-sample Mendelian randomization (MR) and mediation analysis. Results: Globally, the ASPR of female infertility exhibited an increasing trend over the study period. Across all SDI regions, infertility prevalence peaked at ages 35– 40. MR analysis identified poor general health (IVW OR, 1.94; 95% CI, 1.49– 2.52; PFDR = 1.24× 10− 5), elevated waist-to-hip ratio (WHR) (IVW OR, 1.12; 95% CI, 1.04– 1.20; PFDR = 3.26× 10− 3), and neuroticism (IVW OR, 1.10; 95% CI, 1.04– 1.15; PFDR = 1.25× 10− 3) as significant risk factors, whereas higher educational attainment (IVW OR, 0.95; 95% CI, 0.93– 0.97; PFDR = 3.26× 10− 4), greater body fat percentage (IVW OR, 0.67; 95% CI, 0.52– 0.85; PFDR = 4.10× 10− 3) and napping (IVW OR, 0.63; 95% CI, 0.45– 0.89; PFDR = 1.94× 10− 2) had protective effects. Mediation analysis demonstrated that HbA1c and triglycerides (TG) partially mediated the relationship between WHR and infertility, while TG mediated the effect of educational attainment on female infertility. Conclusion: Age-Period-Cohort modeling suggests that shifts in reproductive age patterns, environmental exposures, and cohort-specific risk profiles are key contributors to observed disparities. Targeted public health interventions, including educational promotion, lifestyle modifications, and routine metabolic screening, are essential to mitigate the rising infertility burden in the coming decades.
- 1 September 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 2929-2945
Open AccessGlobal Spatiotemporal Trends and Modifiable Risk Factors for Female Infertility: An Age-Period-Cohort Using Global Burden of Disease Study 2021 and Mendelian Randomization Analysis
Background: This study aims to describe the global burden of female infertility, analyze its spatial and temporal trends, and offer targeted epidemiological insights to support the prevention and management of female infertility. Methods: Drawing on insights from the GBD 2021 study, we analyzed age-standardized prevalence rates (ASPR) of female infertility (1990– 2021) across global regions and Socio-Demographic Index (SDI) categories. We quantified temporal trends using estimated annual percentage change (EAPC) and Age-Period-Cohort analyses across age groups and geographic regions. Furthermore, the causal relationships between 16 modifiable risk factors, 10 serum biomarkers, and female infertility were assessed by two-sample Mendelian randomization (MR) and mediation analysis. Results: Globally, the ASPR of female infertility exhibited an increasing trend over the study period. Across all SDI regions, infertility prevalence peaked at ages 35– 40. MR analysis identified poor general health (IVW OR, 1.94; 95% CI, 1.49– 2.52; PFDR = 1.24× 10− 5), elevated waist-to-hip ratio (WHR) (IVW OR, 1.12; 95% CI, 1.04– 1.20; PFDR = 3.26× 10− 3), and neuroticism (IVW OR, 1.10; 95% CI, 1.04– 1.15; PFDR = 1.25× 10− 3) as significant risk factors, whereas higher educational attainment (IVW OR, 0.95; 95% CI, 0.93– 0.97; PFDR = 3.26× 10− 4), greater body fat percentage (IVW OR, 0.67; 95% CI, 0.52– 0.85; PFDR = 4.10× 10− 3) and napping (IVW OR, 0.63; 95% CI, 0.45– 0.89; PFDR = 1.94× 10− 2) had protective effects. Mediation analysis demonstrated that HbA1c and triglycerides (TG) partially mediated the relationship between WHR and infertility, while TG mediated the effect of educational attainment on female infertility. Conclusion: Age-Period-Cohort modeling suggests that shifts in reproductive age patterns, environmental exposures, and cohort-specific risk profiles are key contributors to observed disparities. Targeted public health interventions, including educational promotion, lifestyle modifications, and routine metabolic screening, are essential to mitigate the rising infertility burden in the coming decades.
- 21 June 2020
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 42 (5) , 526-532
Application of HbA2 levels and red cell indices‐based new model in the differentiation of thalassemia traits from iron deficiency in hypochromic microcytic anemia Cases
Introduction: Thalassemia traits and iron deficiency anemia are the most common types of hypochromic microcytic anemia with similar clinical and laboratory features. It is vital to establish a new screening model based on HbA2 levels and red cell indices for the differentiation of TT from IDA in hypochromic microcytic anemia cases.Method: The data comprised of the red blood cell indices and HbA2 prenatal diagnostic test results of 810 individuals who were identified to conform to the following criteria: MCV < 80 fl or MCH < 26 pg. We launched a new model consisting mainly of significative red cell indices and HbA2 levels, as well as proposing cutoff values by using decision trees and logistic regression analyses. Next, we evaluated our new method by comparing the sensitivity, specificity, positive, and negative predictive values with those of the previous formulas.Results: We put forward a new model and compared it with 5 efficient formulas. The new model exhibited the highest accuracy (0.918), with its sensitivity and specificity calculated as 0.917 and 0.921, respectively. Our new model's Youden index was 0.838, which is higher than the other formulas' Youden indices.Conclusions: The new screening model, based on HbA2 levels and red cell indices, is suitable for the screening of thalassemia patients in the hypochromic microcytic anemia group and has the best efficiency in distinguishing TT and IDA.
- 21 June 2020
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 42 (5) , 526-532
Application of HbA2 levels and red cell indices‐based new model in the differentiation of thalassemia traits from iron deficiency in hypochromic microcytic anemia Cases
Introduction: Thalassemia traits and iron deficiency anemia are the most common types of hypochromic microcytic anemia with similar clinical and laboratory features. It is vital to establish a new screening model based on HbA2 levels and red cell indices for the differentiation of TT from IDA in hypochromic microcytic anemia cases.Method: The data comprised of the red blood cell indices and HbA2 prenatal diagnostic test results of 810 individuals who were identified to conform to the following criteria: MCV < 80 fl or MCH < 26 pg. We launched a new model consisting mainly of significative red cell indices and HbA2 levels, as well as proposing cutoff values by using decision trees and logistic regression analyses. Next, we evaluated our new method by comparing the sensitivity, specificity, positive, and negative predictive values with those of the previous formulas.Results: We put forward a new model and compared it with 5 efficient formulas. The new model exhibited the highest accuracy (0.918), with its sensitivity and specificity calculated as 0.917 and 0.921, respectively. Our new model's Youden index was 0.838, which is higher than the other formulas' Youden indices.Conclusions: The new screening model, based on HbA2 levels and red cell indices, is suitable for the screening of thalassemia patients in the hypochromic microcytic anemia group and has the best efficiency in distinguishing TT and IDA.